( NASDAQ-NMS:ARRY )

News from Array Biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 08, 2017, 10:00 ET Array BioPharma To Present At The 2017 Stifel Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the 2017 Stifel Healthcare...


Sep 09, 2017, 09:30 ET Phase 3 COLUMBUS Part 2 Results in BRAF-Mutant Melanoma Presented at European Society for Medical Oncology Congress

Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today announced results from Part 2 of the Phase 3 COLUMBUS study evaluating binimetinib, a MEK...


Sep 08, 2017, 12:58 ET Phase 3 BEACON CRC Safety Lead-In Results in BRAF-Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress

Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today announced safety results and initial clinical activity from the safety lead-in of the Phase 3...


Aug 09, 2017, 06:00 ET Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017

Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small...


Aug 03, 2017, 11:49 ET Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017 On August 9, 2017

Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2017 and hold a conference call...


Jul 05, 2017, 08:00 ET Array BioPharma Submits New Drug Applications To FDA For Binimetinib And Encorafenib In Advanced Melanoma

Array BioPharma (Nasdaq: ARRY) today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) to...


May 31, 2017, 03:00 ET Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib

Array BioPharma Inc. (Nasdaq: ARRY) and Ono Pharmaceutical Co., Ltd. ("Ono") today announced a license, development and commercialization...


May 30, 2017, 06:59 ET Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration

Array BioPharma (Nasdaq: ARRY) and Bristol-Myers Squibb Company (NYSE:BMY) today announced the companies have entered into a clinical research...


May 10, 2017, 08:00 ET Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017

- COLUMBUS / BRAF-mutant melanoma Part 2 demonstrates positive results and New Drug Application (NDA) filing on track for June or...


May 09, 2017, 16:01 ET Array BioPharma Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS Study of Binimetinib and Encorafenib for BRAF-Mutant Melanoma

Array BioPharma (Nasdaq: ARRY) today announced top-line results from Part 2 of the Phase 3 COLUMBUS study evaluating binimetinib, a MEK inhibitor,...


May 08, 2017, 08:00 ET Array BioPharma Announces Strategic Collaboration with Merck

Array BioPharma Inc. (Nasdaq: ARRY) announced today that it has entered into a clinical trial collaboration agreement with Merck (known as MSD...


May 03, 2017, 08:00 ET Array Biopharma To Report Financial Results For The Third Quarter Of Fiscal 2017 On May 10, 2017

Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2017 and hold a conference call to discuss those...


Feb 09, 2017, 08:30 ET Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017

Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small...


Jan 03, 2017, 09:00 ET Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare...


Nov 22, 2016, 10:00 ET Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual...


Nov 09, 2016, 10:00 ET COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress

Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today jointly announced new results from the pivotal Phase 3 COLUMBUS trial of binimetinib plus...


Oct 03, 2016, 10:12 ET Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

 Array BioPharma Inc. (NasdaqGM: ARRY) announced today the closing of its underwritten public offering of 21,160,000 shares of its common...


Sep 27, 2016, 16:27 ET Array BioPharma Announces Proposed Public Offering of Common Stock

 Array BioPharma (Nasdaq: ARRY) today announced that it has commenced an underwritten public offering of $100 million of shares of its common...


Sep 26, 2016, 07:00 ET Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint

Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today jointly announced top-line results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used...


Sep 14, 2016, 07:30 ET Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA

 Array BioPharma (Nasdaq: ARRY) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a...


Sep 06, 2016, 11:00 ET Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2016 Morgan Stanley Global...


Sep 01, 2016, 08:00 ET Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma

 Array BioPharma (Nasdaq: ARRY) today announced that the FDA has accepted its New Drug Application (NDA) for binimetinib with a target action...


Aug 30, 2016, 08:00 ET Array Presents Data from Cardiovascular Trial with ARRY-797 at the European Society of Cardiology Congress

Array BioPharma (Nasdaq: ARRY) announced today results from a Phase 2 study of ARRY-797, an oral, selective p38 mitogen-activated protein kinase...


Aug 19, 2016, 15:26 ET Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress

 Array BioPharma Inc. (NASDAQ: ARRY) today announced that results from a Phase 2 study of ARRY-797 will be presented at the 2016 European...


Aug 09, 2016, 02:01 ET AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer

 AstraZeneca (LON/STO/NYSE: AZN) today announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in...